Low incidence of venous thromboembolism in inflammatory bowel diseases: Prevalence and predictors from a population-based inception cohort

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 3, 2014, Pages 306-311

  Vegh, Zsuzsanna ^a,b   Golovics, Petra Anna ^a   Lovasz, Barbara Dorottya ^a   Kurti, Zsuzsanna ^a   Gecse, Krisztina Barbara ^a   Szita, Istvan ^b   Balogh, Mihaly ^c   Pandur, Tunde ^b   Lakatos, Laszlo ^b   Lakatos, Peter Laszlo ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Csolnoky Hospital   (Hungary)

^c Grof Eszterhazy Hospital   (Hungary)

Author keywords

Deep venous thrombosis; Inflammatory bowel diseases; Population based inception cohort; Pulmonary embolism; Venous thromboembolism

Indexed keywords

CORTICOSTEROID; STEROID;

ADULT; ARTICLE; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; GROUPS BY AGE; HEMICOLECTOMY; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEOPLASM; ONSET AGE; OUTPATIENT; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SUPERIOR MESENTERIC VEIN; TOTAL COLON RESECTION; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM; CLINICAL TRIAL; COHORT ANALYSIS; COLITIS, ULCERATIVE; HUNGARY; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; SEX RATIO; YOUNG ADULT;

ADULT; AGE OF ONSET; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNGARY; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84922730786     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.985708     Document Type: Article

References (29)

1. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85:430-4.
2. Kappelman MD, Horvath-Puho E, Sandler RS, Rubin DT, Ullman TA, Pedersen L, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011;60: 937-43.
3. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in infl ammatory bowel disease: a cohort study. Lancet 2010;375:657-63.
4. Fumery M, Xiaocang C, Dauchet L, Gower-Rousseau C, Peyrin-Biroulet L, Colombel JF. Thromboembolic events and cardiovascular mortality in in flammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis 2014;8:469-79.
5. Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004;53:542-8.
6. Zitomersky NL, Verhave M, Trenor CC 3rd. Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention. Inflamm Bowel Dis 2011;17:458-70.
7. Grip O, Svensson PJ, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000;35:619-23.
8. Isene R, Bernklev T, Høie O, Langholz E, Tsianos E, Stockbrügger R, et al. EC-IBD Study Group. Thromboembolism in inflammatory bowel disease: results from a prospective, population-based European inception cohort. Scand J Gastroenterol 2014;49:820-5.
9. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24:2-6.
10. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53.
11. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55:i1-i15.
12. Lakatos L, Kiss LS, David G, Pandur T, Erdelyi Z, Mester G, et al. Incidence, disease phenotype at diagnosis and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011;17: 2558-65.
13. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
14. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43:29-32.
15. Papay P, Miehsler W, Tilg H, Petritsch W, Reinisch W, Mayer A, et al. Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohns Colitis 2013; 7:723-9.
16. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008; 103:2272-80.
17. Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010;139:779-87; 787.e1.
18. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158: 585-93.
19. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-8.
20. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232: 155-60.
21. Andreou ER, Koru-Sengul T, Linkins L, Bates SM, Ginsberg JS, Kearon C. Differences in clinical presentation of deep vein thrombosis in men and women. J Thromb Haemost 2008;6:1713-19.
22. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K. Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost 2009;7:1297-303.
23. Zhang G, Xu X, Su W, Xu Q. Smoking and risk of venous thromboembolism: a systematic review. Southeast Asian J Trop Med Public Health 2014;45:736-45.
24. Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z, et al. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflamm Bowel Dis 2013;19:1010-17.
25. Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987;316:707-10.
26. Mokbel M, Carbonnel F, Beaugerie L, Gendre JP, Cosnes J. Effect of smoking on the long-term course of ulcerative colitis. Gastroenterol Clin Biol 1998;22:858-62.
27. Scoville EA, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors. Inflamm Bowel Dis 2014;20:631-6.
28. Liebman HA, Kashani N, Sutherland D, McGehee W, Kam L. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 1998;115:830-4.
29. Novacek G, Miehsler W, Kapiotis S, Katzenschlager R, Speiser W, Vogelsang H. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:685-90.